5-aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis

Frontiers in Microbiology

Volumn 9, Issue JUN, 2018, Pages

  Xu, Jun ^a   Chen, Ning ^a   Wu, Zhe ^a   Song, Yang ^a   Zhang, Yifan ^a   Wu, Na ^a   Zhang, Feng ^a   Ren, Xinhua ^a   Liu, Yulan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

5 aminosalicylic acid; Bacterial correlation; Bacterial dysbiosis; Mucosal microbiota; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; DNA 16S;

ADULT; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DYSBIOSIS; ENDOSCOPY; ESCHERICHIA; FEMALE; FIRMICUTES; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEOBACTERIA; SEQUENCE ANALYSIS; SHIGELLA; ULCERATIVE COLITIS;

EID: 85048566758     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2018.01274     Document Type: Article

References (60)

1. Aguirre de Carcer, D., Cuiv, P. O., Wang, T., Kang, S., Worthley, D., Whitehall, V., et al. (2011). Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon. ISME J. 5, 801-809. doi: 10.1038/ismej.2010.177
2. Andrews, C. N., Griffiths, T. A., Kaufman, J., Vergnolle, N., Surette, M. G., and Rioux, K. P. (2011). Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 34, 374-383. doi: 10.1111/j.1365-2036.2011.04732.x
3. Barman, M., Unold, D., Shifley, K., Amir, E., Hung, K., Bos, N., et al. (2008). Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun. 76, 907-915. doi: 10.1128/IAI.01432-07
4. Belkaid, Y., and Harrison, O. J. (2017). Homeostatic immunity and the microbiota. Immunity 46, 562-576. doi: 10.1016/j.immuni.2017.04.008
5. Bernstein, C. N., Eliakim, A., Fedail, S., Fried, M., Gearry, R., Goh, K. L., et al. (2016). World gastroenterology organisation global guidelines inflammatory bowel disease: update august 2015. J. Clin. Gastroenterol. 50, 803-818. doi: 10.1097/MCG.0000000000000660
6. Butto, L. F., and Haller, D. (2017). Dysbiosis in Crohn's disease-Joint action of stochastic injuries and focal inflammation in the gut. Gut Microbes 8, 53-58. doi: 10.1080/19490976.2016.1270810
7. Byndloss, M. X., Olsan, E. E., Rivera-Chavez, F., Tiffany, C. R., Cevallos, S. A., Lokken, K. L., et al. (2017). Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion. Science 357, 570-575. doi: 10.1126/science.aam9949
8. Cani, P. D., Everard, A., and Duparc, T. (2013). Gut microbiota, enteroendocrine functions and metabolism. Curr. Opin. Pharmacol. 13, 935-940. doi: 10.1016/j.coph.2013.09.008
9. Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., et al. (2010). QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336. doi: 10.1038/nmeth.f.303
10. Chen, W., Liu, F., Ling, Z., Tong, X., and Xiang, C. (2012). Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 7:e39743. doi: 10.1371/journal.pone.0039743
11. Cook, S. I., and Sellin, J. H. (1998). Review article: short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 12, 499-507. doi: 10.1046/j.1365-2036.1998.00337.x
12. Costa, M. C., Silva, G., Ramos, R. V., Staempfli, H. R., Arroyo, L. G., Kim, P., et al. (2015). Characterization and comparison of the bacterial microbiota in different gastrointestinal tract compartments in horses. Vet. J. 205, 74-80. doi: 10.1016/j.tvjl.2015.03.018
13. Du, Z., Hudcovic, T., Mrazek, J., Kozakova, H., Srutkova, D., Schwarzer, M., et al. (2015). Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis. Gut Pathog. 7:32. doi: 10.1186/s13099-015-0080-2
14. Dziarski, R., Park, S. Y., Kashyap, D. R., Dowd, S. E., and Gupta, D. (2016). Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii enhance and Alistipes finegoldii attenuates colitis in mice. PLoS One 11:e0146162. doi: 10.1371/journal.pone.0146162
15. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., and Knight, R. (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200. doi: 10.1093/bioinformatics/btr381
16. Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., et al. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. Am. J. Gastroenterol. 104, 1327-1328. doi: 10.1038/ajg.2009.91
17. Gensollen, T., Iyer, S. S., Kasper, D. L., and Blumberg, R. S. (2016). How colonization by microbiota in early life shapes the immune system. Science 352, 539-544. doi: 10.1126/science.aad9378
18. Gomez de Aguero, M., Ganal-Vonarburg, S. C., Fuhrer, T., Rupp, S., Uchimura, Y., Li, H., et al. (2016). The maternal microbiota drives early postnatal innate immune development. Science 351, 1296-1302. doi: 10.1126/science.aad2571
19. Gu, S., Chen, D., Zhang, J. N., Lv, X., Wang, K., Duan, L. P., et al. (2013). Bacterial community mapping of the mouse gastrointestinal tract. PLoS One 8:e74957. doi: 10.1371/journal.pone.0074957
20. He, J., Yi, L., Hai, L., Ming, L., Gao, W., and Ji, R. (2018). Characterizing the bacterial microbiota in different gastrointestinal tract segments of the Bactrian camel. Sci. Rep. 8:654. doi: 10.1038/s41598-017-18298-7
21. Hedin, C. R., van der Gast, C. J., Stagg, A. J., Lindsay, J. O., and Whelan, K. (2017). The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease. Gut Microbes 8, 359-365. doi: 10.1080/19490976.2017.1284733
22. Imhann, F., Vich Vila, A., Bonder, M. J., Fu, J., Gevers, D., Visschedijk, M. C., et al. (2016). Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67, 108-119. doi: 10.1136/gutjnl-2016-312135
23. Kamada, N., Kim, Y. G., Sham, H. P., Vallance, B. A., Puente, J. L., Martens, E. C., et al. (2012). Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336, 1325-1329. doi: 10.1126/science.1222195
24. Kamada, N., Seo, S. U., Chen, G. Y., and Nunez, G. (2013). Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321-335. doi: 10.1038/nri3430
25. Khan, A. A., Khan, Z., Malik, A., Kalam, M. A., Cash, P., Ashraf, M. T., et al. (2017). Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli. Life Sci. 180, 60-67. doi: 10.1016/j.lfs.2017.05.016
26. Kim, D., Zeng, M. Y., and Nuìnez, G. (2017). The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp. Mol. Med. 49:e339. doi: 10.1038/emm.2017.24
27. Kramer, C. D., and Genco, C. A. (2017). Microbiota, immune subversion, and chronic inflammation. Front. Immunol. 8:255. doi: 10.3389/fimmu.2017.00255
28. Laharie, D. (2017). Towards therapeutic choices in ulcerative colitis. Lancet 390, 98-99. doi: 10.1016/S0140-6736(17)31263-1
29. Lewis, J. D., Chuai, S., Nessel, L., Lichtenstein, G. R., Aberra, F. N., and Ellenberg, J. H. (2008). Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm. Bowel Dis. 14, 1660-1666. doi: 10.1002/ibd.20520
30. Lewis, K., Lutgendorff, F., Phan, V., Soderholm, J. D., Sherman, P. M., and McKay, D. M. (2010). Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm. Bowel Dis. 16, 1138-1148. doi: 10.1002/ibd.21177
31. Li, Q., Wang, C., Tang, C., He, Q., Li, N., and Li, J. (2014). Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J. Clin. Gastroenterol. 48, 513-523
32. Liguori, G., Lamas, B., Richard, M. L., Brandi, G., da Costa, G., Hoffmann, T. W., et al. (2016). Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients. J. Crohns Colitis 10, 296-305. doi: 10.1093/ecco-jcc/jjv209
33. Lopez-Siles, M., Martinez-Medina, M., Abella, C., Busquets, D., Sabat-Mir, M., Duncan, S. H., et al. (2015). Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease. Appl. Environ. Microbiol. 81, 7582-7592. doi: 10.1128/AEM.02006-15
34. Lopez-Siles, M., Martinez-Medina, M., Suris-Valls, R., Aldeguer, X., Sabat-Mir, M., Duncan, S. H., et al. (2016). Changes in the abundance of Faecalibacterium prausnitzii Phylogroups I and II in the intestinal mucosa of inflammatory bowel disease and patients with colorectal cancer. Inflamm. Bowel Dis. 22, 28-41. doi: 10.1097/MIB.0000000000000590
35. Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., et al. (2014). A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275-1283. doi: 10.1136/gutjnl-2013-304833
36. Magoc, T., and Salzberg, S. L. (2011). FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963. doi: 10.1093/bioinformatics/btr507
37. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13:R79. doi: 10.1186/gb-2012-13-9-r79
38. Nguyen, H. T., Dalmasso, G., Muller, S., Carriere, J., Seibold, F., and Darfeuille-Michaud, A. (2014). Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 146, 508-519. doi: 10.1053/j.gastro.2013.10.021
39. Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., et al. (2015). Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447-460. doi: 10.1016/j.cell.2015.01.002
40. Okai, S., Usui, F., Ohta, M., Mori, H., Kurokawa, K., Matsumoto, S., et al. (2017). Intestinal IgA as a modulator of the gut microbiota. Gut Microbes 8, 486-492. doi: 10.1080/19490976.2017.1310357
41. Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Folsch, U. R., et al. (2004). Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693. doi: 10.1136/gut.2003.025403
42. Pascal, V., Pozuelo, M., Borruel, N., Casellas, F., Campos, D., Santiago, A., et al. (2017). A microbial signature for Crohn's disease. Gut 66, 813-822. doi: 10.1136/gutjnl-2016-313235
43. Pickard, J. M., Zeng, M. Y., Caruso, R., and Nunez, G. (2017). Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70-89. doi: 10.1111/imr.12567
44. Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., et al. (2013). The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590-D596. doi: 10.1093/nar/gks1219
45. Rooks, M. G., and Garrett, W. S. (2016). Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341-352. doi: 10.1038/nri.2016.42
46. Sartor, R. B., and Wu, G. D. (2017). Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 152, 327.e-339.e. doi: 10.1053/j.gastro.2016.10.012
47. Sears, C. L. (2009). Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev. 22, 349-369. doi: 10.1128/CMR.00053-08
48. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., et al. (2011). Metagenomic biomarker discovery and explanation. Genome Biol. 12:R60. doi: 10.1186/gb-2011-12-6-r60
49. Sokol, H., Leducq, V., Aschard, H., Pham, H. P., Jegou, S., Landman, C., et al. (2016). Fungal microbiota dysbiosis in IBD. Gut 66, 1039-1048. doi: 10.1136/gutjnl-2015-310746
50. Sokol, H., Leducq, V., Aschard, H., Pham, H. P., Jegou, S., Landman, C., et al. (2017). Fungal microbiota dysbiosis in IBD. Gut 66, 1039-1048. doi: 10.1136/gutjnl-2015-310746
51. Spalinger, M. R., Kasper, S., Chassard, C., Raselli, T., Frey-Wagner, I., Gottier, C., et al. (2015). PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol. 8, 918-929. doi: 10.1038/mi.2014.122
52. Takahashi, K., Nishida, A., Fujimoto, T., Fujii, M., Shioya, M., Imaeda, H., et al. (2016). Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease. Digestion 93, 59-65. doi: 10.1159/000441768
53. Tang, M. S., Poles, J., Leung, J. M., Wolff, M. J., Davenport, M., Lee, S. C., et al. (2015). Inferred metagenomic comparison of mucosal and fecal microbiota from individuals undergoing routine screening colonoscopy reveals similar differences observed during active inflammation. Gut Microbes 6, 48-56. doi: 10.1080/19490976.2014.1000080
54. Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., and Colombel, J. F. (2017). Ulcerative colitis. Lancet 389, 1756-1770. doi: 10.1016/S0140-6736(16)32126-2
55. van der Beek, C. M., Dejong, C. H. C., Troost, F. J., Masclee, A. A. M., and Lenaerts, K. (2017). Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing. Nutr. Rev. 75, 286-305. doi: 10.1093/nutrit/nuw067
56. Viladomiu, M., Kivolowitz, C., Abdulhamid, A., Dogan, B., Victorio, D., Castellanos, J. G., et al. (2017). IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation. Sci. Transl. Med. 9:eaaf9655. doi: 10.1126/scitranslmed.aaf9655
57. Walker, A. (2014). Intestinal colonization and programming of the intestinal immune response. J. Clin. Gastroenterol. 48(Suppl. 1), S8-S11. doi: 10.1097/MCG.0000000000000230
58. Wlodarska, M., Kostic, A. D., and Xavier, R. J. (2015). An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe 17, 577-591. doi: 10.1016/j.chom.2015.04.008
59. Yan, F., and Polk, D. B. (1999). Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells. J. Biol. Chem. 274, 36631-36636. doi: 10.1074/jbc.274.51.36631
60. Zeng, M. Y., Inohara, N., and Nunez, G. (2017). Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 10, 18-26. doi: 10.1038/mi.2016.75